Healthcare provider profile · identity verified

Jasvinder S. Johal, MD

Family Practice · VACAVILLE, CA · NPI 1689726804

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	266	110
Levothyroxine Sodium	Levothyroxine Sodium	191	65
Amlodipine Besylate	Amlodipine Besylate	188	69
Lisinopril	Lisinopril	169	62
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	39
Losartan Potassium	Losartan Potassium	130	56
Gabapentin	Gabapentin	129	56
Trazodone Hcl	Trazodone Hcl	104	33
Famotidine	Famotidine	96	44
Metoprolol Succinate	Metoprolol Succinate	87	36
Metoprolol Tartrate	Metoprolol Tartrate	85	28
Pantoprazole Sodium	Pantoprazole Sodium	83	36
Tamsulosin Hcl	Tamsulosin Hcl	79	31
Glipizide	Glipizide	74	25
Albuterol Sulfate Hfa	Albuterol Sulfate	72	38
Metformin Hcl	Metformin Hcl	66	26
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	63	25
Duloxetine Hcl	Duloxetine Hcl	62	23
Metformin Hcl Er	Metformin Hcl	60	25
Simvastatin	Simvastatin	60	22
Omeprazole	Omeprazole	59	27
Ibuprofen	Ibuprofen	56	28
Jardiance	Empagliflozin	56	23
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	55	11
Alvesco	Ciclesonide	54	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	19
Prednisone	Prednisone	52	40
Atenolol	Atenolol	50	18
Glipizide Er	Glipizide	50	15
Allopurinol	Allopurinol	47	18
Buspirone Hcl	Buspirone Hcl	47	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	46	43
Furosemide	Furosemide	46	20
Sertraline Hcl	Sertraline Hcl	45	17
Nystatin	Nystatin	43	11
Ozempic	Semaglutide	42	13
Rosuvastatin Calcium	Rosuvastatin Calcium	42	23
Alendronate Sodium	Alendronate Sodium	37	17
Hydrochlorothiazide	Hydrochlorothiazide	36	20
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Breyna	Budesonide/Formoterol Fumarate	35	19
Doxycycline Monohydrate	Doxycycline Monohydrate	35	26
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	29
Potassium Chloride	Potassium Chloride	34	13
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Ondansetron Hcl	Ondansetron Hcl	33	14
Cefadroxil	Cefadroxil	32	30
Cephalexin	Cephalexin	32	27
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	13
Hydralazine Hcl	Hydralazine Hcl	29	12
Rizatriptan	Rizatriptan Benzoate	29	suppressed
Hydrocortisone	Hydrocortisone	28	14
Fluticasone Propionate	Fluticasone Propionate	27	12
Chlorthalidone	Chlorthalidone	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	13
Tramadol Hcl	Tramadol Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	17
Pradaxa	Dabigatran Etexilate Mesylate	24	suppressed
Carvedilol	Carvedilol	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Lidocaine Hcl Viscous	Lidocaine Hcl	22	suppressed
Eliquis	Apixaban	21	suppressed
Finasteride	Finasteride	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Topiramate	Topiramate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Ondansetron Odt	Ondansetron	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	suppressed
Promethazine Hcl	Promethazine Hcl	20	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	12
Spironolactone	Spironolactone	18	suppressed
Azithromycin	Azithromycin	17	15
Baclofen	Baclofen	17	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Lactulose	Lactulose	16	13
Meloxicam	Meloxicam	16	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Humulin N	Insulin Nph Human Isophane	15	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Mupirocin	Mupirocin	15	11
Nitroglycerin	Nitroglycerin	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ciclopirox	Ciclopirox	14	suppressed
Diazepam	Diazepam	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	14	suppressed
Linzess	Linaclotide	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Humulin R	Insulin Regular, Human	13	suppressed
Lidocaine-Prilocaine	Lidocaine/Prilocaine	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Belbuca	Buprenorphine Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error